Login
$CNEY
$0.51 +$0.04 (7.54%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q4 FY2025
As of Sep 30, 2025
Q4 FY2024
As of Sep 30, 2024
Q4 FY2023
As of Sep 30, 2023
Q4 FY2022
As of Sep 30, 2022
Q4 FY2021
As of Sep 30, 2021
Cash and restricted cash
Accounts receivable, net
Inventories, net
Advances to suppliers, net
Prepayment for an acquisition of a subsidiary
Due from a related party
Other receivable
Loan to a third party
Acquisition reversal receivable
Prepaid expenses and other current assets
Total current assets
Biological assets, net
Non-Current Assets:
Biological assets, net
Long-term investments
Land use right, net
Long-term deposits
Prepayment for property and equipment
Property and equipment, net
Right-of-use assets
Intangible assets, net
Total non-current assets
Total Assets
Short-term loans
Long-term loans, current portion
Accounts payable
Deferred revenue, current
Proceeds from private placement
Due to a related party
Convertible notes
Due to related parties
Remaining acquisition consideration payable
Taxes payable
Lease liabilities
Prepayment from customers
Accrued expenses and other current liabilities
Total current liabilities
Long-term loans, non-current portion
Deferred revenue, non-current
Deferred tax liabilities
Non-Current Liability:
Due to related parties
Total non-current liability
Total liabilities
Ordinary shares, value
Class A Ordinary Share
Class B Ordinary Share
Additional paid-in capital
Statutory reserves
Accumulated deficits
Accumulated other comprehensive loss
Total shareholders' equity
Total Liabilities and Shareholders' Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support